Literature DB >> 28589750

A unified approach for assessing heterogeneity in age-period-cohort model parameters using random effects.

Pavel Chernyavskiy1,2, Mark P Little1, Philip S Rosenberg2.   

Abstract

Age-period-cohort models are a popular tool for studying population-level rates; for example, trends in cancer incidence and mortality. Age-period-cohort models decompose observed trends into age effects that correlate with natural history, period effects that reveal factors impacting all ages simultaneously (e.g. innovations in screening), and birth cohort effects that reflect differential risk exposures that vary across birth years. Methodology for the analysis of multiple population strata (e.g. ethnicity, cancer registry) within the age-period-cohort framework has not been thoroughly investigated. Here, we outline a general model for characterizing differences in age-period-cohort model parameters for a potentially large number of strata. Our model incorporates stratum-specific random effects for the intercept, the longitudinal age trend, and the model-based estimate of annual percent change (net drift), thereby enabling a comprehensive analysis of heterogeneity. We also extend the standard model to include quadratic terms for age, period, and cohort, along with the corresponding random effects, which quantify possible stratum-specific departures from global curvature. We illustrate the utility of our model with an application to metastatic prostate cancer incidence (2004-2013) in non-Hispanic white and black men, using 17 population-based cancer registries in the Surveillance, Epidemiology, and End Results Program.

Entities:  

Keywords:  Age–period–cohort; Generalized Linear Mixed Model; SEER; cancer incidence; parameter heterogeneity; prostate cancer; random effects

Mesh:

Year:  2017        PMID: 28589750     DOI: 10.1177/0962280217713033

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  8 in total

1.  Evolution of the Oropharynx Cancer Epidemic in the United States: Moderation of Increasing Incidence in Younger Individuals and Shift in the Burden to Older Individuals.

Authors:  Joseph E Tota; Ana F Best; Zachary S Zumsteg; Maura L Gillison; Philip S Rosenberg; Anil K Chaturvedi
Journal:  J Clin Oncol       Date:  2019-04-26       Impact factor: 44.544

2.  Response to DeSantis and Jemal.

Authors:  Brittny C Davis Lynn; Philip S Rosenberg; William F Anderson; Gretchen L Gierach
Journal:  J Natl Cancer Inst       Date:  2019-01-01       Impact factor: 13.506

3.  Increasing risk of uterine cervical cancer among young Japanese women: Comparison of incidence trends in Japan, South Korea and Japanese-Americans between 1985 and 2012.

Authors:  Mai Utada; Pavel Chernyavskiy; Won Jin Lee; Silvia Franceschi; Catherine Sauvaget; Amy Berrington de Gonzalez; Diana R Withrow
Journal:  Int J Cancer       Date:  2018-12-18       Impact factor: 7.396

4.  Breast cancer in Portugal: Temporal trends and age-specific incidence by geographic regions.

Authors:  Gonçalo Forjaz de Lacerda; Scott P Kelly; Joana Bastos; Clara Castro; Alexandra Mayer; Angela B Mariotto; William F Anderson
Journal:  Cancer Epidemiol       Date:  2018-03-13       Impact factor: 2.984

5.  Correlated Poisson models for age-period-cohort analysis.

Authors:  Pavel Chernyavskiy; Mark P Little; Philip S Rosenberg
Journal:  Stat Med       Date:  2017-10-04       Impact factor: 2.373

6.  Spatially varying age-period-cohort analysis with application to US mortality, 2002-2016.

Authors:  Pavel Chernyavskiy; Mark P Little; Philip S Rosenberg
Journal:  Biostatistics       Date:  2020-10-01       Impact factor: 5.899

7.  Hexamaps for Age-Period-Cohort Data Visualization and Implementation in R.

Authors:  Hawre Jalal; Donald S Burke
Journal:  Epidemiology       Date:  2020-11-01       Impact factor: 4.860

8.  Decreasing Incidence of Estrogen Receptor-Negative Breast Cancer in the United States: Trends by Race and Region.

Authors:  Brittny C Davis Lynn; Pavel Chernyavskiy; Gretchen L Gierach; Philip S Rosenberg
Journal:  J Natl Cancer Inst       Date:  2022-02-07       Impact factor: 11.816

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.